VCNXVACCINEX, INC.

Nasdaq vaccinex.com


$ 5.62 $ 0.12 (2.09 %)    

Wednesday, 15-May-2024 14:05:00 EDT
QQQ $ 451.73 $ -1.69 (-0.37 %)
DIA $ 399.14 $ -0.50 (-0.13 %)
SPY $ 528.49 $ -1.44 (-0.27 %)
TLT $ 92.06 $ -0.33 (-0.36 %)
GLD $ 220.06 $ 0.05 (0.02 %)
$ 5.625
$ 5.50
$ 0.00 x 0
$ 0.00 x 0
$ 5.50 - $ 5.62
$ 4.43 - $ 100.80
4,524
na
7.47M
$ 0.81
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 04-02-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-31-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-31-2022 12-31-2021 10-K
11 11-08-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 03-31-2021 12-31-2020 10-K
15 11-13-2020 09-30-2020 10-Q
16 08-14-2020 06-30-2020 10-Q
17 05-14-2020 03-31-2020 10-Q
18 03-09-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-15-2019 03-31-2019 10-Q
22 03-13-2019 12-31-2018 10-K
23 11-13-2018 09-30-2018 10-Q
24 08-14-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 vaccinex-q1-eps-294-sales-10400k-down-from-55000k-yoy

Vaccinex (NASDAQ:VCNX) reported quarterly losses of $(2.94) per share. The company reported $104.00 thousand in sales this quar...

 vaccinex-q4-eps-033-up-from-2310-yoy

Vaccinex (NASDAQ:VCNX) reported quarterly losses of $(0.33) per share. This is a 98.57 percent increase over losses of $(23.10)...

 vaccinex-announces-it-has-entered-into-eight-new-antibody-discovery-agreements-integrating-use-of-its-proprietary-activmab-platform-to-select-antibodies-against-difficult-to-drug-transmembrane-protein-targets

Eight new antibody discovery agreements incorporate Vaccinex's powerful ActivMAb® Drug Discovery Platform ActivMab® platfor...

 why-vaccinex-vcnx-stock-is-trading-lower

Vaccinex shares are trading lower by 7.1%Thursday morning. The company announced a 1-for-14 reverse stock split.

 vaccinex-inc-announces-1-for-14-reverse-stock-split

Vaccinex, Inc., (NASDAQ:VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodeg...

 why-vaccinex-vcnx-stock-is-popping-off

Vaccinex shares are trading higher by 15% during Wednesday's session. The company announced a private placement transaction...

 vaccinex-announces-pricing-of-37m-private-placement-for-the-sale-of-an-aggregate-3838544-shares-of-common-stock

accinex, Inc. (NASDAQ:VCNX) ("Vaccinex" or the "Company"), a clinical-stage biotechnology company pioneering a ...

 vaccinex-q3-eps-109-up-from-165-yoy

Vaccinex (NASDAQ:VCNX) reported quarterly losses of $(1.09) per share. This is a 33.94 percent increase over losses of $(1.65) ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION